Today the FDA granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients with certain kidney conditions. https://go.usa.gov/xvmz4   pic.twitter.com/yt8wD9JLfU

Today the FDA granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients with certain kidney conditions. https://go.usa.gov/xvmz4  pic.twitter.com/yt8wD9JLfU

Source: Food and Drug Adminstration (FDA): CDRHNew - April 29, 2020 Category: Medical Devices Authors: ( at FDAMedia) Source Type: news